The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

Kenneth R. Cooke, Leo Luznik, Stefanie Sarantopoulos, Frances T. Hakim, Madan Jagasia, Daniel H. Fowler, Marcel R M van den Brink, John A. Hansen, Robertson Parkman, David B. Miklos, Paul J. Martin, Sophie Paczesny, Georgia Vogelsang, Steven Pavletic, Jerome Ritz, Kirk R. Schultz, Bruce R. Blazar

Research output: Contribution to journalReview article

74 Citations (Scopus)

Abstract

Chronic graft-versus-host disease (GVHD) is the leading cause of late, nonrelapse mortality and disability in allogeneic hematopoietic cell transplantation recipients and a major obstacle to improving outcomes. The biology of chronic GVHD remains enigmatic, but understanding the underpinnings of the immunologic mechanisms responsible for the initiation and progression of disease is fundamental to developing effective prevention and treatment strategies. The goals of this task force review are as follows: • Summarize the current state of the science regarding pathogenic mechanisms of chronic GVHD and critical knowledge gaps.• Develop working hypotheses/overriding concepts for chronic GVHD development.• Define the usefulness of current preclinical models to test working hypotheses and ultimately discover and develop new therapeutic strategies.• Identify shortcomings of preclinical models, and define criteria for the creation of additional models to address these limitations.This document is intended as a review of our understanding of chronic GVHD biology and therapies resulting from preclinical studies, and as a platform for developing innovative clinical strategies to prevent and treat chronic GVHD.

Original languageEnglish (US)
Pages (from-to)211-234
Number of pages24
JournalBiology of Blood and Marrow Transplantation
Volume23
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

National Institutes of Health (U.S.)
Graft vs Host Disease
Advisory Committees
Consensus
Clinical Trials
Cell Transplantation
Disease Progression
Therapeutics
Mortality

Keywords

  • Blood and marrow transplantation
  • Chronic graft-versus-host disease
  • Clinical manifestations
  • Immune mechanisms

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

The Biology of Chronic Graft-versus-Host Disease : A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. / Cooke, Kenneth R.; Luznik, Leo; Sarantopoulos, Stefanie; Hakim, Frances T.; Jagasia, Madan; Fowler, Daniel H.; van den Brink, Marcel R M; Hansen, John A.; Parkman, Robertson; Miklos, David B.; Martin, Paul J.; Paczesny, Sophie; Vogelsang, Georgia; Pavletic, Steven; Ritz, Jerome; Schultz, Kirk R.; Blazar, Bruce R.

In: Biology of Blood and Marrow Transplantation, Vol. 23, No. 2, 01.02.2017, p. 211-234.

Research output: Contribution to journalReview article

Cooke, KR, Luznik, L, Sarantopoulos, S, Hakim, FT, Jagasia, M, Fowler, DH, van den Brink, MRM, Hansen, JA, Parkman, R, Miklos, DB, Martin, PJ, Paczesny, S, Vogelsang, G, Pavletic, S, Ritz, J, Schultz, KR & Blazar, BR 2017, 'The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease', Biology of Blood and Marrow Transplantation, vol. 23, no. 2, pp. 211-234. https://doi.org/10.1016/j.bbmt.2016.09.023
Cooke, Kenneth R. ; Luznik, Leo ; Sarantopoulos, Stefanie ; Hakim, Frances T. ; Jagasia, Madan ; Fowler, Daniel H. ; van den Brink, Marcel R M ; Hansen, John A. ; Parkman, Robertson ; Miklos, David B. ; Martin, Paul J. ; Paczesny, Sophie ; Vogelsang, Georgia ; Pavletic, Steven ; Ritz, Jerome ; Schultz, Kirk R. ; Blazar, Bruce R. / The Biology of Chronic Graft-versus-Host Disease : A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. In: Biology of Blood and Marrow Transplantation. 2017 ; Vol. 23, No. 2. pp. 211-234.
@article{3808b6e1205e4a9bb9310720086214f5,
title = "The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease",
abstract = "Chronic graft-versus-host disease (GVHD) is the leading cause of late, nonrelapse mortality and disability in allogeneic hematopoietic cell transplantation recipients and a major obstacle to improving outcomes. The biology of chronic GVHD remains enigmatic, but understanding the underpinnings of the immunologic mechanisms responsible for the initiation and progression of disease is fundamental to developing effective prevention and treatment strategies. The goals of this task force review are as follows: • Summarize the current state of the science regarding pathogenic mechanisms of chronic GVHD and critical knowledge gaps.• Develop working hypotheses/overriding concepts for chronic GVHD development.• Define the usefulness of current preclinical models to test working hypotheses and ultimately discover and develop new therapeutic strategies.• Identify shortcomings of preclinical models, and define criteria for the creation of additional models to address these limitations.This document is intended as a review of our understanding of chronic GVHD biology and therapies resulting from preclinical studies, and as a platform for developing innovative clinical strategies to prevent and treat chronic GVHD.",
keywords = "Blood and marrow transplantation, Chronic graft-versus-host disease, Clinical manifestations, Immune mechanisms",
author = "Cooke, {Kenneth R.} and Leo Luznik and Stefanie Sarantopoulos and Hakim, {Frances T.} and Madan Jagasia and Fowler, {Daniel H.} and {van den Brink}, {Marcel R M} and Hansen, {John A.} and Robertson Parkman and Miklos, {David B.} and Martin, {Paul J.} and Sophie Paczesny and Georgia Vogelsang and Steven Pavletic and Jerome Ritz and Schultz, {Kirk R.} and Blazar, {Bruce R.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.bbmt.2016.09.023",
language = "English (US)",
volume = "23",
pages = "211--234",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - The Biology of Chronic Graft-versus-Host Disease

T2 - A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

AU - Cooke, Kenneth R.

AU - Luznik, Leo

AU - Sarantopoulos, Stefanie

AU - Hakim, Frances T.

AU - Jagasia, Madan

AU - Fowler, Daniel H.

AU - van den Brink, Marcel R M

AU - Hansen, John A.

AU - Parkman, Robertson

AU - Miklos, David B.

AU - Martin, Paul J.

AU - Paczesny, Sophie

AU - Vogelsang, Georgia

AU - Pavletic, Steven

AU - Ritz, Jerome

AU - Schultz, Kirk R.

AU - Blazar, Bruce R.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Chronic graft-versus-host disease (GVHD) is the leading cause of late, nonrelapse mortality and disability in allogeneic hematopoietic cell transplantation recipients and a major obstacle to improving outcomes. The biology of chronic GVHD remains enigmatic, but understanding the underpinnings of the immunologic mechanisms responsible for the initiation and progression of disease is fundamental to developing effective prevention and treatment strategies. The goals of this task force review are as follows: • Summarize the current state of the science regarding pathogenic mechanisms of chronic GVHD and critical knowledge gaps.• Develop working hypotheses/overriding concepts for chronic GVHD development.• Define the usefulness of current preclinical models to test working hypotheses and ultimately discover and develop new therapeutic strategies.• Identify shortcomings of preclinical models, and define criteria for the creation of additional models to address these limitations.This document is intended as a review of our understanding of chronic GVHD biology and therapies resulting from preclinical studies, and as a platform for developing innovative clinical strategies to prevent and treat chronic GVHD.

AB - Chronic graft-versus-host disease (GVHD) is the leading cause of late, nonrelapse mortality and disability in allogeneic hematopoietic cell transplantation recipients and a major obstacle to improving outcomes. The biology of chronic GVHD remains enigmatic, but understanding the underpinnings of the immunologic mechanisms responsible for the initiation and progression of disease is fundamental to developing effective prevention and treatment strategies. The goals of this task force review are as follows: • Summarize the current state of the science regarding pathogenic mechanisms of chronic GVHD and critical knowledge gaps.• Develop working hypotheses/overriding concepts for chronic GVHD development.• Define the usefulness of current preclinical models to test working hypotheses and ultimately discover and develop new therapeutic strategies.• Identify shortcomings of preclinical models, and define criteria for the creation of additional models to address these limitations.This document is intended as a review of our understanding of chronic GVHD biology and therapies resulting from preclinical studies, and as a platform for developing innovative clinical strategies to prevent and treat chronic GVHD.

KW - Blood and marrow transplantation

KW - Chronic graft-versus-host disease

KW - Clinical manifestations

KW - Immune mechanisms

UR - http://www.scopus.com/inward/record.url?scp=85008165979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008165979&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2016.09.023

DO - 10.1016/j.bbmt.2016.09.023

M3 - Review article

C2 - 27713092

AN - SCOPUS:85008165979

VL - 23

SP - 211

EP - 234

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 2

ER -